Literature DB >> 22057267

Tumor cell metabolism: an integral view.

Susana Romero-Garcia1, Jose Sullivan Lopez-Gonzalez, José Luis Báez-Viveros, Dolores Aguilar-Cazares, Heriberto Prado-Garcia.   

Abstract

Cancer is a genetic disease that is caused by mutations in oncogenes, tumor suppressor genes and stability genes. The fact that the metabolism of tumor cells is altered has been known for many years. However, the mechanisms and consequences of metabolic reprogramming have just begun to be understood. In this review, an integral view of tumor cell metabolism is presented, showing how metabolic pathways are reprogrammed to satisfy tumor cell proliferation and survival requirements. In tumor cells, glycolysis is strongly enhanced to fulfill the high ATP demands of these cells; glucose carbons are the main building blocks in fatty acid and nucleotide biosynthesis. Glutaminolysis is also increased to satisfy NADPH regeneration, whereas glutamine carbons replenish the Krebs cycle, which produces metabolites that are constantly used for macromolecular biosynthesis. A characteristic feature of the tumor microenvironment is acidosis, which results from the local increase in lactic acid production by tumor cells. This phenomenon is attributed to the carbons from glutamine and glucose, which are also used for lactic acid production. Lactic acidosis also directs the metabolic reprogramming of tumor cells and serves as an additional selective pressure. Finally, we also discuss the role of mitochondria in supporting tumor cell metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057267      PMCID: PMC3280912          DOI: 10.4161/cbt.12.11.18140

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  105 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma.

Authors:  Tetsuo Kawamura; Ryuzo Kanno; Hiroshi Fujii; Toshimitsu Suzuki
Journal:  Pathobiology       Date:  2005       Impact factor: 4.342

3.  Characterization of testis-specific isoenzyme of human pyruvate dehydrogenase.

Authors:  Lioubov G Korotchkina; Sukhdeep Sidhu; Mulchand S Patel
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

4.  High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.

Authors:  Shahab Uddin; Azhar R Hussain; Maqbool Ahmed; Jehad Abubaker; Nasser Al-Sanea; Alaa Abduljabbar; Luai H Ashari; Samar Alhomoud; Fouad Al-Dayel; Prashant Bavi; Khawla S Al-Kuraya
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

5.  Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells.

Authors:  L G Boros; J S Torday; S Lim; S Bassilian; M Cascante; W N Lee
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

Review 6.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

Authors:  Chi V Dang
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

7.  A 13C NMR study on fluxes into the TCA cycle of neuronal and glial tumor cell lines and primary cells.

Authors:  A Brand; J Engelmann; D Leibfritz
Journal:  Biochimie       Date:  1992 Sep-Oct       Impact factor: 4.079

Review 8.  Glutamine homeostasis and mitochondrial dynamics.

Authors:  José M Matés; Juan A Segura; José A Campos-Sandoval; Carolina Lobo; Lorenzo Alonso; Francisco J Alonso; Javier Márquez
Journal:  Int J Biochem Cell Biol       Date:  2009-03-17       Impact factor: 5.085

9.  Metabolic flux determination in C6 glioma cells using carbon-13 distribution upon [1-13C]glucose incubation.

Authors:  J C Portais; R Schuster; M Merle; P Canioni
Journal:  Eur J Biochem       Date:  1993-10-01

10.  TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization.

Authors:  Wenyue Sun; Yan Liu; Chad A Glazer; Chunbo Shao; Sheetal Bhan; Semra Demokan; Ming Zhao; Michelle A Rudek; Patrick K Ha; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

View more
  65 in total

1.  Discovery of a novel inhibitor of NAD(P)(+)-dependent malic enzyme (ME2) by high-throughput screening.

Authors:  Yi Wen; Lei Xu; Fang-lei Chen; Jing Gao; Jing-ya Li; Li-hong Hu; Jia Li
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

2.  Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Authors:  Bingxue Shang; Gaochuan Zhang; Yanyan Pan; Quansheng Zhou
Journal:  Cancer Microenviron       Date:  2012-05-17

3.  Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.

Authors:  Marcel Cetindis; Thorsten Biegner; Adelheid Munz; Peter Teriete; Siegmar Reinert; Martin Grimm
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

Review 4.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

5.  In vitro expansion of U87-MG human glioblastoma cells under hypoxic conditions affects glucose metabolism and subsequent in vivo growth.

Authors:  L Lemaire; F Franconi; B Siegler; C Legendre; E Garcion
Journal:  Tumour Biol       Date:  2015-05-02

6.  Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Yoriko Kajiya; Megumi Jinguji; Nobuaki Nishimata; Shunji Shimaoka; Tohru Nihara; Kuniaki Aridome; Sadao Tanaka; Yoshihiko Fukukura; Atushi Tani; Chihaya Koriyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

7.  An indispensable role of CPT-1a to survive cancer cells during energy stress through rewiring cancer metabolism.

Authors:  Jingtao Luo; Yun Hong; Xiaoan Tao; Xi Wei; Lun Zhang; Qiang Li
Journal:  Tumour Biol       Date:  2016-10-13

8.  LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism.

Authors:  Claudia Tito; Federica Ganci; Andrea Sacconi; Silvia Masciarelli; Giulia Fontemaggi; Claudio Pulito; Enzo Gallo; Valentina Laquintana; Alessia Iaiza; Luciana De Angelis; Anna Benedetti; Jessica Cacciotti; Selenia Miglietta; Maria Bellenghi; Alessandra Carè; Alessandro Fatica; Daniele Diso; Marco Anile; Vincenzo Petrozza; Francesco Facciolo; Gabriele Alessandrini; Edoardo Pescarmona; Federico Venuta; Mirella Marino; Giovanni Blandino; Francesco Fazi
Journal:  Cell Death Dis       Date:  2020-11-07       Impact factor: 8.469

9.  Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation.

Authors:  Karina Negron; Namir Khalasawi; Billy Lu; Chi-Ying Ho; Jason Lee; Siddharth Shenoy; Hai-Quan Mao; Tza-Huei Wang; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2019-04-09       Impact factor: 9.776

Review 10.  Taspase1: a 'misunderstood' protease with translational cancer relevance.

Authors:  D Wünsch; A Hahlbrock; S Jung; T Schirmeister; J van den Boom; O Schilling; S K Knauer; R H Stauber
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.